SZC-6 Promotes Diabetic Wound Healing in Mice by Modulating the M1/M2 Macrophage Ratio and Inhibiting the MyD88/NF-χB Pathway
Authors
Loading...
In vivo experiments highlighted SZC-6's role in improving wound healing in diabetic mice, suggesting it may target macrophages and inflammatory pathways.
Dinh‐Xuan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: